Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.572, 2009-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lyme disease vaccine worth its cost in the US?
Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. :
Access to resources
Recommend
Is pemetrexed cost effective for NSCLC in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 611, 2010-01 ,pp. :
Dalteparin cost effective for VTE prophylaxis in the US?
Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. :
Dalteparin cost effective for VTE prophylaxis in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 488, 2005-01 ,pp. :